PSFE vs CLOV

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 19, 2026

PSFE

63.9
AI Score
VS
PSFE Wins

CLOV

41.6
AI Score

Investment Advisor Scores

PSFE

64score
Recommendation
STRONG BUY

CLOV

42score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric PSFE CLOV Winner
Forward P/E 3.1162 37.7358 PSFE
PEG Ratio 0 0 Tie
Revenue Growth 4.5% 55.6% CLOV
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 63.9/100 41.6/100 PSFE
Profit Margin -11.8% -0.7% CLOV
Beta 1.00 1.00 Tie
AI Recommendation STRONG BUY HOLD PSFE

Relative Price Performance (Last 90 Days)

PSFE 1M: -9.8% · 3M: -26.8% CLOV 1M: +3.2% · 3M: +9.1%

Current Technical Phase

PSFE

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 48

RSI (14): 47.7 · Price: $5.82

CLOV

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (1.2% over 20 days), RSI 54

RSI (14): 54.3 · Price: $4.72

Fundamentals Snapshot

Metric PSFE CLOV
Market Cap — —
Forward P/E 2.6 31.9
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.0% 0.6%
Gross Margin 0.6% 0.2%
Operating Margin 0.0% 0.0%
EPS -3.83 -0.05
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, PSFE is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.